Kuros Biosciences held its Capital Markets Day in Zürich to showcase the commercial progress of MagnetOs, its advanced bone graft product. The company outlined its strategy to expand MagnetOs use in spine, foot, ankle, and trauma markets, emphasizing strong clinical evidence and surgeon engagement. Kuros also shared updates on ongoing clinical trials and new product developments, aiming to scale operations and drive long-term growth. The event included insights from a leading orthopedic surgeon and a patient testimonial, illustrating MagnetOs' impact on bone healing.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
